Aging and osteoporosis in breast and prostate cancer

Screening for Osteoporosis in Men: A Clinical Practice Guideline from the American College of Physicians

(2013) Amir Qaseem et al.   ANNALS OF INTERNAL MEDICINE

Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis

(2013) Catherine MacLean et al.   ANNALS OF INTERNAL MEDICINE

Screening for Osteoporosis: An Update for the U.S. Preventive Services Task Force

(2013) Heidi D. Nelson   ANNALS OF INTERNAL MEDICINE

Targeted exercise against osteoporosis: A systematic review and meta-analysis for optimising bone strength throughout life

(2010) Riku Nikander et al.   BMC Medicine

Bisphosphonate adverse effects, lessons from large databases

(2010) Bo Abrahamsen   CURRENT OPINION IN RHEUMATOLOGY

Effects of weight and body mass index on bone mineral density in men and women: The framingham study

(2010) David T. Felson et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The diagnosis of osteoporosis

(2010) John A. Kanis et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Prevention of Aromatase Inhibitor–Induced Bone Loss Using Risedronate: The SABRE Trial

(2010) Catherine Van Poznak et al.   JOURNAL OF CLINICAL ONCOLOGY

Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer

(2010) Xavier Nogues et al.   MATURITAS

Bisphosphonate Therapeutics in Bone Disease: The Hard and Soft Data on Osteoclast Inhibition

(2010) M. T. Drake et al.   MOLECULAR INTERVENTIONS

Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur

(2010) Dennis M. Black et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy

(2009) P. Hadji et al.   ANNALS OF ONCOLOGY

Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC

(2009) Stephanie L. Hines et al.   BREAST CANCER RESEARCH AND TREATMENT

Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 study

(2009) Georgiana K. Ellis et al.   BREAST CANCER RESEARCH AND TREATMENT

Zoledronic Acid Effectively Prevents Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST Study 36-Month Follow-up Results

(2009) Adam M. Brufsky et al.   Clinical Breast Cancer

Osteoporosis in males and females: Is there really a difference?

(2009) Pascal Guggenbuhl   JOINT BONE SPINE

Effects of Aromatase Inhibition on Bone Mineral Density and Bone Turnover in Older Men with Low Testosterone Levels

(2009) Sherri-Ann M. Burnett-Bowie et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Premature menopause or early menopause: Long-term health consequences

(2009) Lynne T. Shuster et al.   MATURITAS

Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer

(2009) Matthew R. Smith et al.   NEW ENGLAND JOURNAL OF MEDICINE

Practical guidance for the management of aromatase inhibitor-associated bone loss

(2008) P. Hadji et al.   ANNALS OF ONCOLOGY

Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole

(2008) Nigel J. Bundred et al.   CANCER

Guidance for the management of breast cancer treatment-induced bone loss: A consensus position statement from a UK Expert Group

(2008) David M. Reid et al.   CANCER TREATMENT REVIEWS

The Effect of Tamoxifen or Exemestane on Bone Mineral Density During the First 2 Years of Adjuvant Treatment of Postmenopausal Women with Early Breast Cancer

(2008) Stephen Jones et al.   Clinical Breast Cancer

Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer

(2008) J. E. Lester et al.   CLINICAL CANCER RESEARCH

Cancer Treatment Related Bone Loss

(2008) Nazir Khan   Current Oncology

Prevalence of Secondary Causes of Bone Loss Among Breast Cancer Patients With Osteopenia and Osteoporosis

(2008) Pauline M. Camacho et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer

(2008) Georgiana K. Ellis et al.   JOURNAL OF CLINICAL ONCOLOGY

Risedronate Prevents Bone Loss in Breast Cancer Survivors: A 2-Year, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

(2008) Susan L. Greenspan et al.   JOURNAL OF CLINICAL ONCOLOGY

Tamoxifen Use and Osteoporotic Fracture Risk: A Population-Based Analysis

(2008) Andrew L. Cooke et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230

(2008) Richard Eastell et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer Treatment–Induced Bone Loss in Breast and Prostate Cancer

(2008) Fred Saad et al.   JOURNAL OF CLINICAL ONCOLOGY

Are Cancer Survivors/Patients Knowledgeable About Osteoporosis? Results from a Survey of 285 Chemotherapy-treated Cancer Patients and Their Companions

(2008) Heidi McKean et al.   JOURNAL OF NUTRITION EDUCATION AND BEHAVIOR

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

(2008)   LANCET ONCOLOGY

Effects of a multi-component exercise program and calcium–vitamin-D3-fortified milk on bone mineral density in older men: a randomised controlled trial

(2008) S. Kukuljan et al.   OSTEOPOROSIS INTERNATIONAL

Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Bone Mineral Density Deficits in Survivors of Childhood Cancer: Long-term Follow-up Guidelines and Review of the Literature

(2008) K. Wasilewski-Masker et al.   PEDIATRICS

Toremifene Increases Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: Interim Analysis of a Multicenter Phase 3 Clinical Study

(2007) M.R. Smith et al.   JOURNAL OF UROLOGY